NAD+ (500mg) — Research Compound
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells and is essential for biological processes such as energy metabolism and DNA repair. It acts as a primary electron carrier in the mitochondria, facilitating the conversion of nutrients into ATP. Researchers study NAD+ for its role as a substrate for sirtuins and PARP enzymes, investigating how its declining levels contribute to cellular ageing and metabolic dysfunction.
Findings from early-stage clinical trials have reported:
- Increases in intracellular NAD+ levels and improved mitochondrial function observed in research models
- Enhanced DNA repair mechanisms and reductions in cellular senescence markers reported in-vitro
- Improvements in systemic metabolic markers and insulin sensitivity noted in experimental studies
- Observed increases in physical endurance and muscle function reported in ageing research subjects
Researchers utilize NAD+ to investigate the fundamental mechanisms of cellular energy homeostasis and longevity. By focusing on its role in mitochondrial biogenesis and genomic stability, it serves as a vital tool for exploring the reversal of age-related physiological decline. This compound is a primary focus for research into the biological triggers of metabolic health and the preservation of cellular integrity.
Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.
Used solely for in vitro experiments and cannot be:
- Used in clinical trials involving humans
- Administered to humans as part of an experiment or investigation
- Supplied to another party for human investigational use
| IDENTIFICATION | |
| Product Name | NAD+ 500 mg |
| Catalogue Number | RP-NAD-01 |
| CAS Number | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 g/mol |
| Molecular Formula | C21H27N7O14P2 |
| Peptide Sequence | N/A (small molecule) |
| PHYSICAL AND CHEMICAL PROPERTIES | |
| Active Ingredient | NAD+ |
| Appearance | White to off-white lyophilised powder |
| Melting Point | Not applicable (decomposes before melting) |
| ANALYTICAL AND QUALITY CONTROL | |
| Mass Spectrum | Conforms to specification |
| Structural Confirmation | Consistent with theoretical structure |
| RESEARCH USE AND SAFETY | |
| Caution | Handle using appropriate PPE and in compliance with relevant laboratory safety standards. |
| Intended Use | For laboratory research use only. Not for human or veterinary use. |
| Hazard Classification | Not classified as hazardous under GHS for research quantities |
| STORAGE, HANDLING AND STABILITY | |
| Storage Temperature, Opened | -20 °C, minimise freeze–thaw cycles |
| Storage Temperature, Unopened | -20 °C recommended for long-term storage |
| Shelf Life | 2 years unopened under recommended conditions |
| Reconstitution Stability | Stable for up to 28 days at 2–8 °C in aqueous solution under sterile conditions |
Certificate of Analysis – NAD+ (99% Purity Verified)
| COMPOUND IDENTIFICATION | |
| Product Name | NAD+ 500mg Spray |
| Batch / Reference ID | NA501216 |
| Sample Form | White powder in glass vial |
| ANALYTICAL RESULTS | |
| Chemical Purity | 99% (Verified) |
| Measured Content | 531.20mg (± 0.05mg) |
| Test Method | HPLC (High-Performance Liquid Chromatography) |
| LABORATORY TESTING INFORMATION | |
| Analysis Period | 06 Feb 2026 – 10 Feb 2026 |
| Laboratory Order # | 100012224 |
| QUALITY ASSURANCE | |
| Quality Testing Standards | All River Peptides products undergo batch-level laboratory analysis to verify compound identity and confirm purity levels. Learn more on our Quality Testing & Purity Verification page. |


